
Tushen Zhihe provides companies with AI-powered protein design and generative protein engineering capabilities to accelerate discovery and design cycles. The company uses machine learning and generative models to design, optimize, and control protein sequences, offering a lightweight, controllable platform for protein generation. It operates as a B2B SaaS and service provider for biotech, pharmaceutical, and research organizations and supports integration with laboratory workflows and computational pipelines. Tushen Zhihe targets the synthetic biology and drug discovery markets where computational protein design can reduce experimental iteration and speed time-to-result.

Tushen Zhihe provides companies with AI-powered protein design and generative protein engineering capabilities to accelerate discovery and design cycles. The company uses machine learning and generative models to design, optimize, and control protein sequences, offering a lightweight, controllable platform for protein generation. It operates as a B2B SaaS and service provider for biotech, pharmaceutical, and research organizations and supports integration with laboratory workflows and computational pipelines. Tushen Zhihe targets the synthetic biology and drug discovery markets where computational protein design can reduce experimental iteration and speed time-to-result.